WASHINGTON — Fresh off the Federal Trade Commission’s successful challenges to four hospital mergers, the Biden administration’s new majority on the commission is primed to more aggressively combat consolidation in
The Biden administration’s new majority on the commission is primed to more aggressively combat consolidation in the health care industry than it has in past years.
Fresh off the Federal Trade Commission's successful challenges to four hospital mergers, the Biden administration's new majority on the commission is primed to more aggressively combat consolidation in the health care industry than it has in past years.
Although hospital mergers were supposed to improve cost efficiency, experts agree that the creation of huge conglomerates and hospital networks has driven up U.S. medical costs, which are by far the highest in the world. Many enjoy near-monopoly pricing power.